Bronchoscopic Lung Volume Reduction

1

Review clinical trials related to Bronchoscopic Lung Volume Reduction. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Bronchoscopic Lung Volume Reduction in Management of Localized Emphysema

Emphysema is a progressive phenotype of chronic Obstructive Pulmonary Disease (COPD), poses a significant global health burden characterized by irreversible lung parenchymal destruction and airspace enlargement. In recent years, bronchoscopic lung volume reduction (BLVR) has considerable interest as a minimally invasive approach to reducing hyperinflation and improving lung function in patients with emphysema. BLVR techniques aim to achieve lung volume reduction by occluding or ablating emphysematous lung tissue through endobronchial delivery of various agents. Many techniques are available for BLVR as coil, endo-bronchial valve, and biological as thrombin, autologous blood and chemicals as silver nitrate solution.

Participants needed: 30
Trial details
Age: 40-75Biological sex: AllType: InterventionalSponsor: Mansoura University HospitalUpdated: May 29, 2025Locations: 1
Eligibility criteria

COPD of grade III and IV according to GOLD 2024 staging of COPD with localized (...

Significant co-morbidities that limits exercise capacity or prognosis as cardiov... [+6]